Rank | Gene Set | Z-score |
---|---|---|
1 | glucocorticoid biosynthetic process (GO:0006704) | 5.91539610 |
2 | estrogen biosynthetic process (GO:0006703) | 5.44634634 |
3 | lysine metabolic process (GO:0006553) | 4.91965242 |
4 | lysine catabolic process (GO:0006554) | 4.91965242 |
5 | L-phenylalanine catabolic process (GO:0006559) | 4.89838370 |
6 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 4.89838370 |
7 | L-phenylalanine metabolic process (GO:0006558) | 4.66293813 |
8 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 4.66293813 |
9 | aromatic amino acid family catabolic process (GO:0009074) | 4.34126259 |
10 | androgen biosynthetic process (GO:0006702) | 4.24856425 |
11 | glucocorticoid metabolic process (GO:0008211) | 4.20347617 |
12 | drug transmembrane transport (GO:0006855) | 4.15330464 |
13 | glyoxylate metabolic process (GO:0046487) | 4.14300961 |
14 | valine metabolic process (GO:0006573) | 4.10976742 |
15 | alpha-linolenic acid metabolic process (GO:0036109) | 4.09751109 |
16 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 4.07674817 |
17 | cysteine metabolic process (GO:0006534) | 3.93583007 |
18 | 2-oxoglutarate metabolic process (GO:0006103) | 3.88956027 |
19 | fatty acid beta-oxidation (GO:0006635) | 3.87231979 |
20 | kynurenine metabolic process (GO:0070189) | 3.87180153 |
21 | negative regulation of protein activation cascade (GO:2000258) | 3.84443942 |
22 | tryptophan catabolic process (GO:0006569) | 3.82857880 |
23 | indole-containing compound catabolic process (GO:0042436) | 3.82857880 |
24 | indolalkylamine catabolic process (GO:0046218) | 3.82857880 |
25 | short-chain fatty acid metabolic process (GO:0046459) | 3.70728143 |
26 | tryptophan metabolic process (GO:0006568) | 3.69354284 |
27 | fatty acid oxidation (GO:0019395) | 3.68634667 |
28 | response to follicle-stimulating hormone (GO:0032354) | 3.67461267 |
29 | sulfur amino acid catabolic process (GO:0000098) | 3.63804653 |
30 | negative regulation of complement activation (GO:0045916) | 3.63043615 |
31 | amino-acid betaine metabolic process (GO:0006577) | 3.60963964 |
32 | lipid oxidation (GO:0034440) | 3.59667254 |
33 | bile acid biosynthetic process (GO:0006699) | 3.58954132 |
34 | urate metabolic process (GO:0046415) | 3.55533598 |
35 | homocysteine metabolic process (GO:0050667) | 3.54827824 |
36 | aspartate family amino acid catabolic process (GO:0009068) | 3.49221555 |
37 | regulation of cholesterol homeostasis (GO:2000188) | 3.47671777 |
38 | androgen metabolic process (GO:0008209) | 3.44232540 |
39 | endocrine hormone secretion (GO:0060986) | 3.42555811 |
40 | 4-hydroxyproline metabolic process (GO:0019471) | 3.41296743 |
41 | desmosome organization (GO:0002934) | 3.41205988 |
42 | branched-chain amino acid metabolic process (GO:0009081) | 3.40786456 |
43 | protein carboxylation (GO:0018214) | 3.39048841 |
44 | peptidyl-glutamic acid carboxylation (GO:0017187) | 3.39048841 |
45 | fatty acid catabolic process (GO:0009062) | 3.38510066 |
46 | tricarboxylic acid metabolic process (GO:0072350) | 3.31096466 |
47 | estrogen metabolic process (GO:0008210) | 3.28934582 |
48 | branched-chain amino acid catabolic process (GO:0009083) | 3.26070118 |
49 | response to mercury ion (GO:0046689) | 3.23558855 |
50 | benzene-containing compound metabolic process (GO:0042537) | 3.22185689 |
51 | triglyceride homeostasis (GO:0070328) | 3.21427899 |
52 | acylglycerol homeostasis (GO:0055090) | 3.21427899 |
53 | cellular ketone body metabolic process (GO:0046950) | 3.21422668 |
54 | acetyl-CoA metabolic process (GO:0006084) | 3.20041529 |
55 | fatty acid transmembrane transport (GO:1902001) | 3.18864981 |
56 | carnitine metabolic process (GO:0009437) | 3.18612232 |
57 | monocarboxylic acid catabolic process (GO:0072329) | 3.18255159 |
58 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 3.17979041 |
59 | drug transport (GO:0015893) | 3.17599057 |
60 | negative regulation of fibrinolysis (GO:0051918) | 3.15337859 |
61 | high-density lipoprotein particle remodeling (GO:0034375) | 3.14814256 |
62 | carnitine shuttle (GO:0006853) | 3.14024965 |
63 | cellular modified amino acid catabolic process (GO:0042219) | 3.12043572 |
64 | alpha-amino acid catabolic process (GO:1901606) | 3.08207540 |
65 | bundle of His cell to Purkinje myocyte communication (GO:0086069) | 3.04275092 |
66 | bile acid metabolic process (GO:0008206) | 3.03791218 |
67 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 3.03381868 |
68 | regulation of triglyceride catabolic process (GO:0010896) | 3.03379112 |
69 | aromatic amino acid family metabolic process (GO:0009072) | 3.02510883 |
70 | serine family amino acid catabolic process (GO:0009071) | 3.00848618 |
71 | cellular glucuronidation (GO:0052695) | 2.99924439 |
72 | quaternary ammonium group transport (GO:0015697) | 2.99893763 |
73 | ethanol oxidation (GO:0006069) | 2.99561048 |
74 | biotin metabolic process (GO:0006768) | 2.99164593 |
75 | cellular amino acid catabolic process (GO:0009063) | 2.99049349 |
76 | regulation of fibrinolysis (GO:0051917) | 2.98621078 |
77 | transcytosis (GO:0045056) | 2.97978225 |
78 | COPII vesicle coating (GO:0048208) | 2.97666173 |
79 | drug catabolic process (GO:0042737) | 2.97628539 |
80 | amino-acid betaine transport (GO:0015838) | 2.96699213 |
81 | carnitine transport (GO:0015879) | 2.96699213 |
82 | intestinal cholesterol absorption (GO:0030299) | 2.95656130 |
83 | excretion (GO:0007588) | 2.94491629 |
84 | COPI coating of Golgi vesicle (GO:0048205) | 2.92711355 |
85 | Golgi transport vesicle coating (GO:0048200) | 2.92711355 |
86 | regulation of protein activation cascade (GO:2000257) | 2.91772319 |
87 | tyrosine metabolic process (GO:0006570) | 2.91609515 |
88 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 2.90311587 |
89 | positive regulation of fatty acid oxidation (GO:0046321) | 2.89170007 |
90 | iron ion import (GO:0097286) | 2.87949840 |
91 | organic acid catabolic process (GO:0016054) | 2.86656643 |
92 | carboxylic acid catabolic process (GO:0046395) | 2.86656643 |
93 | regulation of sequestering of triglyceride (GO:0010889) | 2.85715417 |
94 | glutamate metabolic process (GO:0006536) | 2.83664136 |
95 | reverse cholesterol transport (GO:0043691) | 2.82642671 |
96 | metanephric tubule development (GO:0072170) | 2.82411094 |
97 | metanephric nephron tubule development (GO:0072234) | 2.82411094 |
98 | cellular response to growth hormone stimulus (GO:0071378) | 2.81359836 |
99 | complement activation, alternative pathway (GO:0006957) | 2.81180157 |
100 | regulation of complement activation (GO:0030449) | 2.78837557 |
101 | polyol transport (GO:0015791) | 2.76165273 |
102 | C21-steroid hormone biosynthetic process (GO:0006700) | 2.75770491 |
103 | ketone body metabolic process (GO:1902224) | 2.75320447 |
104 | regulation of fatty acid beta-oxidation (GO:0031998) | 2.74165171 |
105 | phospholipid homeostasis (GO:0055091) | 2.74140874 |
106 | regulation of apoptotic cell clearance (GO:2000425) | 2.74034756 |
107 | plasma lipoprotein particle clearance (GO:0034381) | 2.73864568 |
108 | low-density lipoprotein particle clearance (GO:0034383) | 2.73615908 |
109 | carnitine transmembrane transport (GO:1902603) | 2.72240617 |
110 | urea cycle (GO:0000050) | 2.72179708 |
111 | urea metabolic process (GO:0019627) | 2.72179708 |
112 | metanephric nephron epithelium development (GO:0072243) | 2.71556950 |
113 | blood coagulation, intrinsic pathway (GO:0007597) | 2.71501280 |
114 | epoxygenase P450 pathway (GO:0019373) | 2.71389516 |
115 | lymphangiogenesis (GO:0001946) | 2.70820708 |
116 | protein retention in ER lumen (GO:0006621) | 2.70582517 |
117 | complement activation, classical pathway (GO:0006958) | 2.68613867 |
118 | regulation of fatty acid oxidation (GO:0046320) | 2.67246173 |
119 | ovulation from ovarian follicle (GO:0001542) | 2.66325603 |
120 | glucuronate metabolic process (GO:0019585) | 2.66032067 |
121 | uronic acid metabolic process (GO:0006063) | 2.66032067 |
122 | regulation of plasminogen activation (GO:0010755) | 2.65329358 |
123 | endocardial cushion development (GO:0003197) | 2.65066767 |
124 | anterior/posterior axis specification, embryo (GO:0008595) | 2.64949091 |
125 | indolalkylamine metabolic process (GO:0006586) | 2.64742428 |
126 | coenzyme catabolic process (GO:0009109) | 2.63131434 |
127 | positive regulation of glycolytic process (GO:0045821) | 2.62852307 |
128 | protein activation cascade (GO:0072376) | 2.61907916 |
129 | embryonic retina morphogenesis in camera-type eye (GO:0060059) | 2.61712002 |
130 | ethanol metabolic process (GO:0006067) | 2.59356129 |
131 | hormone biosynthetic process (GO:0042446) | 2.57931772 |
132 | positive regulation of hormone metabolic process (GO:0032352) | 2.57450569 |
133 | omega-hydroxylase P450 pathway (GO:0097267) | 2.56068255 |
134 | negative regulation of humoral immune response (GO:0002921) | 2.55573795 |
135 | smooth muscle tissue development (GO:0048745) | 2.51463604 |
136 | protein-lipid complex remodeling (GO:0034368) | 2.50304831 |
137 | macromolecular complex remodeling (GO:0034367) | 2.50304831 |
138 | plasma lipoprotein particle remodeling (GO:0034369) | 2.50304831 |
139 | regulation of phospholipase A2 activity (GO:0032429) | 2.49383420 |
140 | C21-steroid hormone metabolic process (GO:0008207) | 2.47472374 |
141 | progesterone metabolic process (GO:0042448) | 2.47028237 |
142 | cholesterol efflux (GO:0033344) | 2.46244833 |
143 | metanephric epithelium development (GO:0072207) | 2.45879940 |
144 | flavonoid metabolic process (GO:0009812) | 2.45271681 |
145 | glomerular basement membrane development (GO:0032836) | 2.44417420 |
146 | complement activation (GO:0006956) | 2.44049851 |
147 | regulation of transforming growth factor beta2 production (GO:0032909) | 2.42257033 |
148 | interkinetic nuclear migration (GO:0022027) | 2.41883129 |
149 | import into cell (GO:0098657) | 2.41627133 |
150 | prostate gland growth (GO:0060736) | 2.38998764 |
151 | negative regulation of cholesterol transport (GO:0032375) | 2.38787302 |
152 | negative regulation of sterol transport (GO:0032372) | 2.38787302 |
153 | negative regulation of lipase activity (GO:0060192) | 2.37740169 |
154 | aminoglycoside antibiotic metabolic process (GO:0030647) | 2.36463466 |
155 | basement membrane organization (GO:0071711) | 2.36453774 |
156 | regulation of humoral immune response (GO:0002920) | 2.36402504 |
157 | renal absorption (GO:0070293) | 2.36293559 |
158 | response to water (GO:0009415) | 2.33815802 |
159 | female pregnancy (GO:0007565) | 2.33248523 |
160 | toxin metabolic process (GO:0009404) | 2.32312990 |
161 | collecting duct development (GO:0072044) | 2.30602436 |
162 | negative regulation of fatty acid transport (GO:2000192) | 2.29775983 |
163 | lipoprotein metabolic process (GO:0042157) | 2.29435481 |
164 | regulation of steroid hormone biosynthetic process (GO:0090030) | 2.28956517 |
Rank | Gene Set | Z-score |
---|---|---|
1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 6.85522878 |
2 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 5.13990404 |
3 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 4.57508817 |
4 | * LXR_22158963_ChIP-Seq_LIVER_Mouse | 4.48810483 |
5 | * PPARA_22158963_ChIP-Seq_LIVER_Mouse | 4.48658138 |
6 | * NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 3.11992393 |
7 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 3.07194426 |
8 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 3.03466642 |
9 | CLOCK_20551151_ChIP-Seq_293T_Human | 2.96324438 |
10 | * TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.77558220 |
11 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 2.70999420 |
12 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 2.48389309 |
13 | * TRIM28_21343339_ChIP-Seq_HEK293_Human | 2.47781054 |
14 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 2.42319291 |
15 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.24153664 |
16 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 2.18235693 |
17 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 2.11837134 |
18 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 2.08190085 |
19 | * AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 2.07589033 |
20 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.97752641 |
21 | * EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.84108890 |
22 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.83633117 |
23 | * FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.80520137 |
24 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.74733413 |
25 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.72692406 |
26 | * TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.68449327 |
27 | * TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.68449327 |
28 | * SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.64589980 |
29 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.63124378 |
30 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.61929014 |
31 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.61198178 |
32 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.59883370 |
33 | GATA1_22025678_ChIP-Seq_K562_Human | 1.56833384 |
34 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.55956776 |
35 | * ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.54679621 |
36 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.54193638 |
37 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.51528590 |
38 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.51364764 |
39 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.49669373 |
40 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 1.47896536 |
41 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.47105278 |
42 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.45778046 |
43 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.45131721 |
44 | * GATA4_25053715_ChIP-Seq_YYC3_Human | 1.43286960 |
45 | CJUN_26792858_Chip-Seq_BT549_Human | 1.41620755 |
46 | * CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.41323913 |
47 | * CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.41204818 |
48 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.38986807 |
49 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.38986807 |
50 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.38473733 |
51 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 1.38434218 |
52 | * TP53_18474530_ChIP-ChIP_U2OS_Human | 1.37725549 |
53 | * POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.37047951 |
54 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.33114133 |
55 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.32591711 |
56 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.32530167 |
57 | * SOX2_20726797_ChIP-Seq_SW620_Human | 1.31452462 |
58 | * AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.29886136 |
59 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.29112999 |
60 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.28965008 |
61 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.26945527 |
62 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.26445848 |
63 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.25828308 |
64 | CDX2_22108803_ChIP-Seq_LS180_Human | 1.24364475 |
65 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 1.24096687 |
66 | * FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.22669410 |
67 | TP53_16413492_ChIP-PET_HCT116_Human | 1.22505703 |
68 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.21619663 |
69 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.20347893 |
70 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.19541052 |
71 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.18709766 |
72 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.17413378 |
73 | * SMAD3_21741376_ChIP-Seq_HESCs_Human | 1.17253541 |
74 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.16557397 |
75 | * HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.13267583 |
76 | AR_25329375_ChIP-Seq_VCAP_Human | 1.11944532 |
77 | * TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 1.11914950 |
78 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 1.10441436 |
79 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 1.10195616 |
80 | STAT3_23295773_ChIP-Seq_U87_Human | 1.09781637 |
81 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.08975832 |
82 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.08914909 |
83 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.08099136 |
84 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.07408801 |
85 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 1.07023575 |
86 | P300_19829295_ChIP-Seq_ESCs_Human | 1.06914975 |
87 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.06891739 |
88 | * GATA3_24758297_ChIP-Seq_MCF-7_Human | 1.06722917 |
89 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.05272214 |
90 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.05145941 |
91 | * CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 1.05124734 |
92 | * TCF4_23295773_ChIP-Seq_U87_Human | 1.03874754 |
93 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.02397847 |
94 | * FOXA1_25552417_ChIP-Seq_VCAP_Human | 1.02245267 |
95 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.02190523 |
96 | * GATA6_25053715_ChIP-Seq_YYC3_Human | 1.02189614 |
97 | * WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.01979105 |
98 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.01411372 |
99 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.01221480 |
100 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.00694810 |
101 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.00215203 |
102 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 0.99288426 |
103 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 0.98690923 |
104 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 0.98443144 |
105 | TCF4_22108803_ChIP-Seq_LS180_Human | 0.98032467 |
106 | * TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 0.97256165 |
107 | * TP63_23658742_ChIP-Seq_EP156T_Human | 0.97082366 |
108 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.96633294 |
109 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.96608510 |
110 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 0.95192036 |
111 | * SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 0.94597194 |
112 | * SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 0.94597194 |
113 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.90652137 |
114 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 0.90623407 |
115 | GATA1_19941826_ChIP-Seq_K562_Human | 0.89482827 |
116 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.89070549 |
117 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 0.88696484 |
118 | FOXM1_26456572_ChIP-Seq_MCF-7_Human | 0.87355765 |
119 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.87270987 |
120 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 0.87173829 |
121 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 0.85644867 |
122 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.85090212 |
123 | MEF2A_21415370_ChIP-Seq_HL-1_Mouse | 0.83922876 |
124 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.82944754 |
125 | * PPARG_20887899_ChIP-Seq_3T3-L1_Mouse | 0.82641819 |
126 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.81383356 |
127 | FOXP2_23625967_ChIP-Seq_PFSK-1_AND_SK-N-MC_Human | 0.80988886 |
128 | RXR_22108803_ChIP-Seq_LS180_Human | 0.80357866 |
129 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.79773458 |
130 | * RUNX1_27514584_Chip-Seq_MCF-7_Human | 0.79731171 |
131 | GATA2_19941826_ChIP-Seq_K562_Human | 0.79571551 |
132 | AHR_22903824_ChIP-Seq_MCF-7_Human | 0.79011344 |
133 | * P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.78943468 |
134 | * ISL1_27105846_Chip-Seq_CPCs_Mouse | 0.78606163 |
135 | RACK7_27058665_Chip-Seq_MCF-7_Human | 0.78109800 |
136 | * PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 0.75050146 |
137 | BRD4_25478319_ChIP-Seq_HGPS_Human | 0.74948924 |
138 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.74626368 |
139 | NKX2-5_21415370_ChIP-Seq_HL-1_Mouse | 0.74550614 |
140 | ATF3_27146783_Chip-Seq_COLON_Human | 0.74515394 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0002139_abnormal_hepatobiliary_system | 5.31991468 |
2 | MP0005360_urolithiasis | 4.94977478 |
3 | MP0005085_abnormal_gallbladder_physiolo | 3.80444249 |
4 | MP0005365_abnormal_bile_salt | 3.76462289 |
5 | MP0003195_calcinosis | 3.33668550 |
6 | MP0008875_abnormal_xenobiotic_pharmacok | 3.15200540 |
7 | MP0003252_abnormal_bile_duct | 3.03092090 |
8 | MP0004043_abnormal_pH_regulation | 2.41860979 |
9 | MP0005332_abnormal_amino_acid | 2.34255197 |
10 | MP0002837_dystrophic_cardiac_calcinosis | 2.31982666 |
11 | MP0003941_abnormal_skin_development | 2.21010514 |
12 | MP0010329_abnormal_lipoprotein_level | 2.10397500 |
13 | MP0003300_gastrointestinal_ulcer | 1.99980544 |
14 | MP0005670_abnormal_white_adipose | 1.93732889 |
15 | MP0009643_abnormal_urine_homeostasis | 1.90479204 |
16 | MP0004084_abnormal_cardiac_muscle | 1.90262791 |
17 | MP0010368_abnormal_lymphatic_system | 1.89229263 |
18 | MP0003705_abnormal_hypodermis_morpholog | 1.87609142 |
19 | MP0001666_abnormal_nutrient_absorption | 1.84608561 |
20 | MP0009384_cardiac_valve_regurgitation | 1.84580684 |
21 | MP0002138_abnormal_hepatobiliary_system | 1.79979322 |
22 | MP0005503_abnormal_tendon_morphology | 1.78479599 |
23 | MP0009697_abnormal_copulation | 1.76724649 |
24 | MP0003806_abnormal_nucleotide_metabolis | 1.74644044 |
25 | MP0004019_abnormal_vitamin_homeostasis | 1.70073583 |
26 | MP0003950_abnormal_plasma_membrane | 1.68892326 |
27 | MP0004272_abnormal_basement_membrane | 1.55506556 |
28 | MP0002118_abnormal_lipid_homeostasis | 1.55288661 |
29 | MP0001765_abnormal_ion_homeostasis | 1.54686054 |
30 | MP0001756_abnormal_urination | 1.52961443 |
31 | MP0005666_abnormal_adipose_tissue | 1.49465068 |
32 | MP0003191_abnormal_cellular_cholesterol | 1.48193918 |
33 | MP0005319_abnormal_enzyme/_coenzyme | 1.47848994 |
34 | MP0005083_abnormal_biliary_tract | 1.44493259 |
35 | MP0000609_abnormal_liver_physiology | 1.41995580 |
36 | MP0005379_endocrine/exocrine_gland_phen | 1.40276355 |
37 | MP0002877_abnormal_melanocyte_morpholog | 1.40087667 |
38 | MP0004130_abnormal_muscle_cell | 1.38693977 |
39 | MP0010678_abnormal_skin_adnexa | 1.36691841 |
40 | MP0009780_abnormal_chondrocyte_physiolo | 1.36622296 |
41 | MP0005330_cardiomyopathy | 1.34856628 |
42 | MP0002909_abnormal_adrenal_gland | 1.34749090 |
43 | MP0001879_abnormal_lymphatic_vessel | 1.32878459 |
44 | MP0010234_abnormal_vibrissa_follicle | 1.32811639 |
45 | MP0003959_abnormal_lean_body | 1.27746269 |
46 | MP0004036_abnormal_muscle_relaxation | 1.26908890 |
47 | MP0005636_abnormal_mineral_homeostasis | 1.26176943 |
48 | MP0005409_darkened_coat_color | 1.26062933 |
49 | MP0002009_preneoplasia | 1.25093584 |
50 | MP0000383_abnormal_hair_follicle | 1.24699666 |
51 | MP0005220_abnormal_exocrine_pancreas | 1.24494504 |
52 | MP0008004_abnormal_stomach_pH | 1.22112245 |
53 | MP0003011_delayed_dark_adaptation | 1.21600245 |
54 | MP0009115_abnormal_fat_cell | 1.21012552 |
55 | MP0002896_abnormal_bone_mineralization | 1.19637281 |
56 | MP0002108_abnormal_muscle_morphology | 1.14507602 |
57 | MP0003868_abnormal_feces_composition | 1.14141002 |
58 | MP0000230_abnormal_systemic_arterial | 1.14137833 |
59 | MP0006138_congestive_heart_failure | 1.14110189 |
60 | MP0010386_abnormal_urinary_bladder | 1.14094837 |
61 | MP0005375_adipose_tissue_phenotype | 1.12516487 |
62 | MP0002136_abnormal_kidney_physiology | 1.07567693 |
63 | MP0009840_abnormal_foam_cell | 1.06328156 |
64 | MP0000538_abnormal_urinary_bladder | 1.05395847 |
65 | MP0002796_impaired_skin_barrier | 1.05076360 |
66 | MP0002972_abnormal_cardiac_muscle | 1.04374876 |
67 | MP0002168_other_aberrant_phenotype | 1.03870752 |
68 | MP0010630_abnormal_cardiac_muscle | 1.03018231 |
69 | MP0004264_abnormal_extraembryonic_tissu | 1.01417195 |
70 | MP0008775_abnormal_heart_ventricle | 1.01380921 |
71 | MP0005084_abnormal_gallbladder_morpholo | 1.01282349 |
72 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.00495162 |
73 | MP0002928_abnormal_bile_duct | 1.00385802 |
74 | MP0004215_abnormal_myocardial_fiber | 1.00058017 |
75 | MP0003890_abnormal_embryonic-extraembry | 1.00030800 |
76 | MP0004185_abnormal_adipocyte_glucose | 0.98417168 |
77 | MP0002876_abnormal_thyroid_physiology | 0.97487130 |
78 | MP0008961_abnormal_basal_metabolism | 0.96001079 |
79 | MP0003566_abnormal_cell_adhesion | 0.95006501 |
80 | MP0008438_abnormal_cutaneous_collagen | 0.94781263 |
81 | MP0003279_aneurysm | 0.94651283 |
82 | MP0002078_abnormal_glucose_homeostasis | 0.94519460 |
83 | MP0005275_abnormal_skin_tensile | 0.94040777 |
84 | MP0001544_abnormal_cardiovascular_syste | 0.91961630 |
85 | MP0005385_cardiovascular_system_phenoty | 0.91961630 |
86 | MP0001270_distended_abdomen | 0.91802516 |
87 | MP0000013_abnormal_adipose_tissue | 0.91239706 |
88 | MP0004087_abnormal_muscle_fiber | 0.89816304 |
89 | MP0004484_altered_response_of | 0.89696269 |
90 | MP0010352_gastrointestinal_tract_polyps | 0.89679085 |
91 | MP0006054_spinal_hemorrhage | 0.89489899 |
92 | MP0005164_abnormal_response_to | 0.89023655 |
93 | MP0003186_abnormal_redox_activity | 0.88274271 |
94 | MP0000003_abnormal_adipose_tissue | 0.88221578 |
95 | MP0001944_abnormal_pancreas_morphology | 0.87645861 |
96 | MP0003045_fibrosis | 0.87478152 |
97 | MP0003646_muscle_fatigue | 0.87194731 |
98 | MP0005620_abnormal_muscle_contractility | 0.85716737 |
99 | MP0000767_abnormal_smooth_muscle | 0.84996553 |
100 | MP0000598_abnormal_liver_morphology | 0.82768525 |
101 | MP0000751_myopathy | 0.82636429 |
102 | MP0005451_abnormal_body_composition | 0.81440008 |
103 | MP0005647_abnormal_sex_gland | 0.80811811 |
104 | MP0005595_abnormal_vascular_smooth | 0.80431377 |
105 | MP0003953_abnormal_hormone_level | 0.80430359 |
106 | MP0003283_abnormal_digestive_organ | 0.79037685 |
107 | MP0005395_other_phenotype | 0.77856666 |
108 | MP0005408_hypopigmentation | 0.77722839 |
109 | MP0000163_abnormal_cartilage_morphology | 0.77702661 |
110 | MP0000762_abnormal_tongue_morphology | 0.77491023 |
111 | MP0001661_extended_life_span | 0.77376536 |
112 | MP0002971_abnormal_brown_adipose | 0.77375162 |
113 | MP0002933_joint_inflammation | 0.75412916 |
114 | MP0002166_altered_tumor_susceptibility | 0.75128493 |
115 | MP0000749_muscle_degeneration | 0.74318725 |
116 | MP0000534_abnormal_ureter_morphology | 0.73981259 |
117 | MP0000639_abnormal_adrenal_gland | 0.73599662 |
118 | MP0005187_abnormal_penis_morphology | 0.73153699 |
119 | MP0004782_abnormal_surfactant_physiolog | 0.72906928 |
120 | MP0002128_abnormal_blood_circulation | 0.72118370 |
121 | MP0002060_abnormal_skin_morphology | 0.71026992 |
122 | MP0002295_abnormal_pulmonary_circulatio | 0.68716051 |
123 | MP0001958_emphysema | 0.67522511 |
124 | MP0005023_abnormal_wound_healing | 0.67423644 |
125 | MP0004085_abnormal_heartbeat | 0.67172617 |
126 | MP0005623_abnormal_meninges_morphology | 0.66068790 |
127 | MP0005165_increased_susceptibility_to | 0.65678374 |
128 | MP0001915_intracranial_hemorrhage | 0.65293372 |
129 | MP0005334_abnormal_fat_pad | 0.65091172 |
130 | MP0005448_abnormal_energy_balance | 0.64734280 |
131 | MP0003091_abnormal_cell_migration | 0.64502710 |
132 | MP0002269_muscular_atrophy | 0.64496588 |
133 | MP0009642_abnormal_blood_homeostasis | 0.64224893 |
134 | MP0001764_abnormal_homeostasis | 0.63758871 |
135 | MP0006276_abnormal_autonomic_nervous | 0.62894643 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Hypoglycemic coma (HP:0001325) | 4.87220164 |
2 | Intrahepatic cholestasis (HP:0001406) | 4.10411608 |
3 | Ketoacidosis (HP:0001993) | 4.01039248 |
4 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 3.98319651 |
5 | Deep venous thrombosis (HP:0002625) | 3.90126538 |
6 | Ketosis (HP:0001946) | 3.85001894 |
7 | Xanthomatosis (HP:0000991) | 3.68329792 |
8 | Hyperglycinuria (HP:0003108) | 3.60354652 |
9 | Decreased circulating renin level (HP:0003351) | 3.59874735 |
10 | Abnormality of the axillary hair (HP:0100134) | 3.47020746 |
11 | Abnormality of secondary sexual hair (HP:0009888) | 3.47020746 |
12 | Abnormality of complement system (HP:0005339) | 3.42442669 |
13 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 3.41631888 |
14 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.38767550 |
15 | Gout (HP:0001997) | 3.32717145 |
16 | Abnormality of glycine metabolism (HP:0010895) | 3.23190337 |
17 | Abnormality of serine family amino acid metabolism (HP:0010894) | 3.23190337 |
18 | Hypoplastic ischia (HP:0003175) | 3.21601758 |
19 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 3.20752962 |
20 | Hyperinsulinemic hypoglycemia (HP:0000825) | 3.20034546 |
21 | Hypoglycemic seizures (HP:0002173) | 3.18044203 |
22 | Hyperammonemia (HP:0001987) | 3.16322341 |
23 | Generalized aminoaciduria (HP:0002909) | 3.15839614 |
24 | Right ventricular cardiomyopathy (HP:0011663) | 3.13375860 |
25 | Increased circulating renin level (HP:0000848) | 3.11489446 |
26 | Epiphyseal dysplasia (HP:0002656) | 3.07716968 |
27 | Aortic aneurysm (HP:0004942) | 3.02890300 |
28 | Abnormality of the ischium (HP:0003174) | 3.01767479 |
29 | Potter facies (HP:0002009) | 3.00674962 |
30 | Facial shape deformation (HP:0011334) | 3.00674962 |
31 | Abnormal tarsal ossification (HP:0008369) | 2.99974092 |
32 | Mitral stenosis (HP:0001718) | 2.90472418 |
33 | Glomerulonephritis (HP:0000099) | 2.90282607 |
34 | Abnormality of purine metabolism (HP:0004352) | 2.88519414 |
35 | Abnormality of the common coagulation pathway (HP:0010990) | 2.86262958 |
36 | Abnormality of magnesium homeostasis (HP:0004921) | 2.82069395 |
37 | Hypoalphalipoproteinemia (HP:0003233) | 2.78290958 |
38 | Proximal tubulopathy (HP:0000114) | 2.76650201 |
39 | Prolonged partial thromboplastin time (HP:0003645) | 2.72744188 |
40 | Abnormality of the intrinsic pathway (HP:0010989) | 2.71340493 |
41 | Polydipsia (HP:0001959) | 2.70717729 |
42 | Abnormal drinking behavior (HP:0030082) | 2.70717729 |
43 | Hyperglycinemia (HP:0002154) | 2.70339548 |
44 | Protuberant abdomen (HP:0001538) | 2.68440820 |
45 | Adrenal overactivity (HP:0002717) | 2.66427732 |
46 | Hydroxyprolinuria (HP:0003080) | 2.65143740 |
47 | Abnormality of proline metabolism (HP:0010907) | 2.65143740 |
48 | Hypokalemic alkalosis (HP:0001949) | 2.64055674 |
49 | Hyperglycemia (HP:0003074) | 2.60604731 |
50 | Renal salt wasting (HP:0000127) | 2.60483178 |
51 | Abnormality of chloride homeostasis (HP:0011422) | 2.58758226 |
52 | Hyperlipoproteinemia (HP:0010980) | 2.57047284 |
53 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 2.55173957 |
54 | Flat acetabular roof (HP:0003180) | 2.54048065 |
55 | Increased purine levels (HP:0004368) | 2.53466618 |
56 | Hyperuricemia (HP:0002149) | 2.53466618 |
57 | Symptomatic seizures (HP:0011145) | 2.49215921 |
58 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.48407663 |
59 | Dicarboxylic aciduria (HP:0003215) | 2.48407663 |
60 | Epidermoid cyst (HP:0200040) | 2.47714820 |
61 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 2.46730717 |
62 | Metaphyseal cupping (HP:0003021) | 2.44017516 |
63 | Abnormal foot bone ossification (HP:0010675) | 2.43016169 |
64 | Cupped ribs (HP:0000887) | 2.42918663 |
65 | Abnormality of carpal bone ossification (HP:0006257) | 2.42423293 |
66 | Fair hair (HP:0002286) | 2.40292162 |
67 | Hyperactive renin-angiotensin system (HP:0000841) | 2.40223320 |
68 | Fat malabsorption (HP:0002630) | 2.39658389 |
69 | Abnormality of renin-angiotensin system (HP:0000847) | 2.38265475 |
70 | Joint hemorrhage (HP:0005261) | 2.35904621 |
71 | Nephritis (HP:0000123) | 2.33739862 |
72 | Hypolipoproteinemia (HP:0010981) | 2.33019106 |
73 | Complement deficiency (HP:0004431) | 2.32500918 |
74 | Lymphangioma (HP:0100764) | 2.30087379 |
75 | Metaphyseal dysplasia (HP:0100255) | 2.28715755 |
76 | Ventricular tachycardia (HP:0004756) | 2.26925439 |
77 | Aortic dissection (HP:0002647) | 2.25803112 |
78 | Vascular calcification (HP:0004934) | 2.25149899 |
79 | Hyperaldosteronism (HP:0000859) | 2.24268744 |
80 | Metabolic alkalosis (HP:0200114) | 2.22508505 |
81 | Myoglobinuria (HP:0002913) | 2.22437826 |
82 | Abnormal cartilage morphology (HP:0002763) | 2.21208942 |
83 | Spontaneous abortion (HP:0005268) | 2.20195198 |
84 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 2.20058994 |
85 | Metabolic acidosis (HP:0001942) | 2.19512391 |
86 | Abnormality of nucleobase metabolism (HP:0010932) | 2.19438809 |
87 | Tetany (HP:0001281) | 2.19218351 |
88 | Muscle fiber splitting (HP:0003555) | 2.18402942 |
89 | Lip pit (HP:0100267) | 2.17397323 |
90 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 2.17101204 |
91 | Vitreoretinal degeneration (HP:0000655) | 2.15734540 |
92 | Protrusio acetabuli (HP:0003179) | 2.13453020 |
93 | Myocardial infarction (HP:0001658) | 2.12618657 |
94 | Cardiovascular calcification (HP:0011915) | 2.12344934 |
95 | Abnormal hand bone ossification (HP:0010660) | 2.10455788 |
96 | Abnormal urine output (HP:0012590) | 2.09206151 |
97 | Late onset (HP:0003584) | 2.09052189 |
98 | Hyporeflexia of lower limbs (HP:0002600) | 2.07980154 |
99 | Hypobetalipoproteinemia (HP:0003563) | 2.07508064 |
100 | Aplasia/Hypoplasia of the pubic bone (HP:0009104) | 2.07145077 |
101 | Alkalosis (HP:0001948) | 2.06527174 |
102 | Hypercalciuria (HP:0002150) | 2.05978043 |
103 | Pancreatic islet-cell hyperplasia (HP:0004510) | 2.05916754 |
104 | Skin nodule (HP:0200036) | 2.05777989 |
105 | Conjugated hyperbilirubinemia (HP:0002908) | 2.03236727 |
106 | Hepatocellular carcinoma (HP:0001402) | 2.03207564 |
107 | Abnormality of renal excretion (HP:0011036) | 2.00596430 |
108 | Abnormality of the nasal septum (HP:0000419) | 2.00009623 |
109 | Tubular atrophy (HP:0000092) | 1.97027294 |
110 | Hypothermia (HP:0002045) | 1.96035847 |
111 | Polyuria (HP:0000103) | 1.95967380 |
112 | Esophageal varix (HP:0002040) | 1.95234519 |
113 | Focal segmental glomerulosclerosis (HP:0000097) | 1.94582339 |
114 | Insulin-resistant diabetes mellitus (HP:0000831) | 1.94409452 |
115 | Exercise-induced muscle cramps (HP:0003710) | 1.92836679 |
116 | Renal cortical cysts (HP:0000803) | 1.92544262 |
117 | Rickets (HP:0002748) | 1.92514174 |
118 | Abnormality of potassium homeostasis (HP:0011042) | 1.92301244 |
119 | Delayed epiphyseal ossification (HP:0002663) | 1.92222372 |
120 | Increased connective tissue (HP:0009025) | 1.90698498 |
121 | Sudden death (HP:0001699) | 1.90402000 |
122 | Hemorrhage of the eye (HP:0011885) | 1.90305369 |
123 | Enlarged kidneys (HP:0000105) | 1.89970448 |
124 | Glycosuria (HP:0003076) | 1.89805139 |
125 | Abnormality of urine glucose concentration (HP:0011016) | 1.89805139 |
126 | Abnormality of Sharpey fibers (HP:0100685) | 1.89685051 |
127 | Abnormality of methionine metabolism (HP:0010901) | 1.89265355 |
128 | Vascular tortuosity (HP:0004948) | 1.89008951 |
129 | Hypokalemia (HP:0002900) | 1.88692137 |
130 | Chondrocalcinosis (HP:0000934) | 1.88690521 |
131 | Delayed CNS myelination (HP:0002188) | 1.88005532 |
132 | Pigmentary retinal degeneration (HP:0001146) | 1.87270371 |
133 | Sensorimotor neuropathy (HP:0007141) | 1.85125396 |
134 | Hypomagnesemia (HP:0002917) | 1.85010244 |
135 | Hyperkalemia (HP:0002153) | 1.83646621 |
136 | Accelerated skeletal maturation (HP:0005616) | 1.83498743 |
137 | Systemic lupus erythematosus (HP:0002725) | 1.82618492 |
138 | Abnormal ossification of hand bones (HP:0005921) | 1.82447565 |
139 | Sparse lateral eyebrow (HP:0005338) | 1.76757425 |
140 | Amelogenesis imperfecta (HP:0000705) | 1.76660872 |
141 | Osteomalacia (HP:0002749) | 1.75493911 |
142 | Overgrowth (HP:0001548) | 1.73243486 |
143 | Generalized hypopigmentation of hair (HP:0011358) | 1.72744720 |
144 | Enlarged penis (HP:0000040) | 1.71949944 |
145 | Arterial tortuosity (HP:0005116) | 1.71829048 |
146 | Advanced eruption of teeth (HP:0006288) | 1.70627568 |
147 | Aplasia of the musculature (HP:0100854) | 1.70180963 |
148 | Glomerulosclerosis (HP:0000096) | 1.65969210 |
149 | Testicular neoplasm (HP:0010788) | 1.64031651 |
150 | Visceral angiomatosis (HP:0100761) | 1.63729710 |
151 | Hypophosphatemic rickets (HP:0004912) | 1.63614930 |
152 | Hypoplasia of the iris (HP:0007676) | 1.63255166 |
153 | Hypotension (HP:0002615) | 1.60716600 |
Rank | Gene Set | Z-score |
---|---|---|
1 | BCKDK | 3.61580249 |
2 | WNK4 | 3.44376270 |
3 | LATS1 | 3.33028785 |
4 | ERN1 | 2.96114775 |
5 | INSRR | 2.88272105 |
6 | TRIB3 | 2.80129588 |
7 | TAOK3 | 2.79219470 |
8 | SIK1 | 2.59479322 |
9 | FRK | 2.56690749 |
10 | FGFR4 | 2.12757979 |
11 | STK38L | 2.08960539 |
12 | MAP3K3 | 1.98624063 |
13 | TTN | 1.88984661 |
14 | WNK3 | 1.83697594 |
15 | PKN2 | 1.79902095 |
16 | TIE1 | 1.65651800 |
17 | NUAK1 | 1.51796433 |
18 | STK39 | 1.49326560 |
19 | ACVR1B | 1.46861250 |
20 | PTK6 | 1.46859444 |
21 | MYLK | 1.43989944 |
22 | EPHB1 | 1.43051887 |
23 | TGFBR2 | 1.42700302 |
24 | CDK12 | 1.42163626 |
25 | PDGFRA | 1.33426504 |
26 | MST1R | 1.28723721 |
27 | PIK3CA | 1.28703950 |
28 | OXSR1 | 1.26600432 |
29 | EPHA3 | 1.21023300 |
30 | EEF2K | 1.19726541 |
31 | DMPK | 1.18500982 |
32 | FGFR2 | 1.17183569 |
33 | NEK9 | 1.15899297 |
34 | TRPM7 | 1.14130520 |
35 | PTK2 | 1.13567007 |
36 | PDK2 | 1.12749343 |
37 | STK3 | 1.09956696 |
38 | BMPR1B | 1.09952699 |
39 | MET | 1.09916248 |
40 | STK38 | 1.08232164 |
41 | AKT3 | 1.08067370 |
42 | RIPK1 | 1.07630569 |
43 | PAK3 | 1.07559699 |
44 | PDK4 | 1.07554321 |
45 | PDK3 | 1.07554321 |
46 | FER | 1.06607030 |
47 | PRKAA2 | 1.05449984 |
48 | LRRK2 | 1.03668544 |
49 | WNK1 | 1.03083244 |
50 | MST4 | 1.02080646 |
51 | STK10 | 1.01516374 |
52 | STK24 | 1.00252567 |
53 | FGFR3 | 0.98672345 |
54 | NLK | 0.97939656 |
55 | MAP3K2 | 0.96860799 |
56 | DDR2 | 0.91938594 |
57 | FLT3 | 0.90899899 |
58 | GRK1 | 0.89586221 |
59 | LMTK2 | 0.88925662 |
60 | KDR | 0.88337385 |
61 | ICK | 0.87549309 |
62 | MAPK15 | 0.85310176 |
63 | PIK3CG | 0.84517978 |
64 | GSK3A | 0.83871035 |
65 | PRKG2 | 0.82564367 |
66 | MAP3K7 | 0.80748108 |
67 | PRKD3 | 0.79339342 |
68 | PRKD1 | 0.79309718 |
69 | CAMK1D | 0.77439719 |
70 | JAK1 | 0.76083817 |
71 | PRKD2 | 0.75921738 |
72 | PRKAA1 | 0.75768570 |
73 | PRKCH | 0.75090597 |
74 | EPHB2 | 0.70320446 |
75 | MTOR | 0.69976907 |
76 | PAK2 | 0.69965527 |
77 | MARK2 | 0.69851479 |
78 | MAP2K3 | 0.69645086 |
79 | CDC42BPA | 0.69280793 |
80 | RET | 0.66172532 |
81 | BRSK2 | 0.65420176 |
82 | PDGFRB | 0.65239026 |
83 | EPHA2 | 0.64781349 |
84 | OBSCN | 0.63960053 |
85 | ERBB4 | 0.63007194 |
86 | SGK1 | 0.62236796 |
87 | PRKCE | 0.60879582 |
88 | SGK3 | 0.59647894 |
89 | MAPKAPK3 | 0.57237469 |
90 | ROCK1 | 0.56394419 |
91 | CAMK1G | 0.53917474 |
92 | IRAK3 | 0.53251644 |
93 | ITK | 0.52438783 |
94 | CDK6 | 0.51246475 |
95 | NTRK3 | 0.49234760 |
96 | HIPK2 | 0.47115269 |
97 | IGF1R | 0.46275940 |
98 | MAPK12 | 0.46246945 |
99 | MAP2K1 | 0.45838494 |
100 | MAP3K9 | 0.44755909 |
101 | JAK2 | 0.43661345 |
102 | EIF2AK3 | 0.43122186 |
103 | MAPK11 | 0.41057800 |
104 | IRAK1 | 0.40190679 |
105 | TGFBR1 | 0.39793706 |
106 | LATS2 | 0.39672515 |
107 | MAPK7 | 0.39448749 |
108 | DAPK2 | 0.39164462 |
109 | SGK223 | 0.38360352 |
110 | SGK494 | 0.38360352 |
111 | MAP2K2 | 0.37973711 |
112 | PDPK1 | 0.37493416 |
113 | PNCK | 0.37352840 |
114 | FGFR1 | 0.37152135 |
115 | SGK2 | 0.36882150 |
116 | DYRK1B | 0.36487015 |
117 | ADRBK1 | 0.36435725 |
118 | PDK1 | 0.35527242 |
119 | MAP3K1 | 0.35075703 |
120 | CDK9 | 0.34748422 |
121 | NEK6 | 0.34621058 |
122 | ERBB3 | 0.34338246 |
123 | MELK | 0.33876101 |
124 | CHUK | 0.33765026 |
125 | MAPKAPK5 | 0.32916538 |
126 | RPS6KB1 | 0.31592529 |
127 | YES1 | 0.31513939 |
128 | BRD4 | 0.31472752 |
129 | PRKCZ | 0.30869292 |
130 | ERBB2 | 0.30795313 |
131 | PINK1 | 0.30682279 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Fatty acid degradation_Homo sapiens_hsa00071 | 3.02055828 |
2 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.97455533 |
3 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.83017373 |
4 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 2.83012472 |
5 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.75226977 |
6 | Nitrogen metabolism_Homo sapiens_hsa00910 | 2.73013935 |
7 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.57288734 |
8 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.55764191 |
9 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.35773470 |
10 | Fatty acid metabolism_Homo sapiens_hsa01212 | 2.34130194 |
11 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.23769879 |
12 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.22454292 |
13 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.18599644 |
14 | Sulfur metabolism_Homo sapiens_hsa00920 | 2.08807797 |
15 | PPAR signaling pathway_Homo sapiens_hsa03320 | 2.06925309 |
16 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 2.05414420 |
17 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 2.05227287 |
18 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.03042830 |
19 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 2.00620676 |
20 | Peroxisome_Homo sapiens_hsa04146 | 1.89661451 |
21 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.89477683 |
22 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.72046621 |
23 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.71571956 |
24 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.68992602 |
25 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.64195432 |
26 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.63757173 |
27 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.50412056 |
28 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.49620480 |
29 | Bile secretion_Homo sapiens_hsa04976 | 1.49258714 |
30 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.45549295 |
31 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.42673534 |
32 | Lysine degradation_Homo sapiens_hsa00310 | 1.41159752 |
33 | Histidine metabolism_Homo sapiens_hsa00340 | 1.34700153 |
34 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.31883419 |
35 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.29717107 |
36 | Carbon metabolism_Homo sapiens_hsa01200 | 1.26746409 |
37 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.23770485 |
38 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.21294134 |
39 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.18455662 |
40 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.17869776 |
41 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.16889242 |
42 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 1.16350653 |
43 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.13758308 |
44 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.13668244 |
45 | ABC transporters_Homo sapiens_hsa02010 | 1.08743355 |
46 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.08691371 |
47 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.07841546 |
48 | Retinol metabolism_Homo sapiens_hsa00830 | 1.03003715 |
49 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.96552605 |
50 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.96257748 |
51 | Insulin resistance_Homo sapiens_hsa04931 | 0.92694763 |
52 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.92660270 |
53 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.91495102 |
54 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.90350865 |
55 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.86170155 |
56 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.83989448 |
57 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.83310020 |
58 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.77702483 |
59 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.77701267 |
60 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.76964409 |
61 | Renin secretion_Homo sapiens_hsa04924 | 0.72962233 |
62 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.72912690 |
63 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.72726643 |
64 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.72263709 |
65 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.71134757 |
66 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.70659219 |
67 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.69444715 |
68 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.66282416 |
69 | Protein export_Homo sapiens_hsa03060 | 0.64587156 |
70 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.63089675 |
71 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.62913920 |
72 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.61179880 |
73 | Focal adhesion_Homo sapiens_hsa04510 | 0.58900988 |
74 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.58249861 |
75 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.56848256 |
76 | Prion diseases_Homo sapiens_hsa05020 | 0.54246813 |
77 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.52788480 |
78 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.52238350 |
79 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.50799274 |
80 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.49824841 |
81 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.49109424 |
82 | Adherens junction_Homo sapiens_hsa04520 | 0.48725224 |
83 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.47776666 |
84 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.47061197 |
85 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.46200509 |
86 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.43903728 |
87 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.43039845 |
88 | Tight junction_Homo sapiens_hsa04530 | 0.42865086 |
89 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.42669431 |
90 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.41893863 |
91 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.41646342 |
92 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.40950736 |
93 | Galactose metabolism_Homo sapiens_hsa00052 | 0.40900301 |
94 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.39578645 |
95 | Other glycan degradation_Homo sapiens_hsa00511 | 0.37111280 |
96 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.37091652 |
97 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.35345469 |
98 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.33582194 |
99 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.33173183 |
100 | Metabolic pathways_Homo sapiens_hsa01100 | 0.30406738 |
101 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.29993422 |
102 | Salivary secretion_Homo sapiens_hsa04970 | 0.26977103 |
103 | Amoebiasis_Homo sapiens_hsa05146 | 0.26349503 |
104 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.26243394 |
105 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.25441441 |
106 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.24769711 |
107 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.23177957 |
108 | Circadian rhythm_Homo sapiens_hsa04710 | 0.22452843 |
109 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.21962387 |
110 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.21863636 |
111 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.21092669 |
112 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.19514336 |
113 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.18725382 |
114 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.18271610 |
115 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.17877876 |
116 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.17654516 |
117 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.17281590 |
118 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.16998743 |
119 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.16778875 |
120 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.14537118 |
121 | Mineral absorption_Homo sapiens_hsa04978 | 0.14195172 |
122 | Prostate cancer_Homo sapiens_hsa05215 | 0.13160056 |
123 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.12621077 |
124 | Bladder cancer_Homo sapiens_hsa05219 | 0.12555514 |